Aeglea Bio Therapeutics Volatility
AGLEDelisted Stock | USD 0.59 0.01 1.72% |
We have found twenty-nine technical indicators for Aeglea Bio Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Aeglea Bio's mean deviation of 11.03, and Risk Adjusted Performance of 0.0975 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%. Key indicators related to Aeglea Bio's volatility include:
90 Days Market Risk | Chance Of Distress | 90 Days Economic Sensitivity |
Aeglea Bio Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Aeglea daily returns, and it is calculated using variance and standard deviation. We also use Aeglea's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Aeglea Bio volatility.
Aeglea |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Aeglea Bio can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game as hey may decide to buy additional stocks of Aeglea Bio at lower prices to lower their average cost per share. Similarly, when the prices of Aeglea Bio's stock rise, investors can sell out and invest the proceeds in other equities with better opportunities.
Moving against Aeglea Stock
0.81 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.8 | PPERY | Bank Mandiri Persero | PairCorr |
0.76 | PBCRY | Bank Central Asia | PairCorr |
0.75 | BKRKY | Bank Rakyat | PairCorr |
0.74 | PPERF | Bank Mandiri Persero | PairCorr |
0.74 | SHG | Shinhan Financial | PairCorr |
0.72 | PTBRY | Bank Negara Indonesia Normal Trading | PairCorr |
0.71 | KO | Coca Cola Fiscal Year End 11th of February 2025 | PairCorr |
0.68 | BKRKF | PT Bank Rakyat | PairCorr |
Aeglea Bio Market Sensitivity And Downside Risk
Aeglea Bio's beta coefficient measures the volatility of Aeglea stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Aeglea stock's returns against your selected market. In other words, Aeglea Bio's beta of 4.92 provides an investor with an approximation of how much risk Aeglea Bio stock can potentially add to one of your existing portfolios. Aeglea Bio Therapeutics is displaying above-average volatility over the selected time horizon. Aeglea Bio Therapeutics is a potential penny stock. Although Aeglea Bio may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Aeglea Bio Therapeutics. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Aeglea instrument if you perfectly time your entry and exit. However, remember that penny delisted stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
3 Months Beta |Analyze Aeglea Bio Therapeutics Demand TrendCheck current 90 days Aeglea Bio correlation with market (Dow Jones Industrial)Aeglea Beta |
Aeglea standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 0.0 |
It is essential to understand the difference between upside risk (as represented by Aeglea Bio's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Aeglea Bio's daily returns or price. Since the actual investment returns on holding a position in aeglea stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Aeglea Bio.
Aeglea Bio Therapeutics Stock Volatility Analysis
Volatility refers to the frequency at which Aeglea Bio delisted stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Aeglea Bio's price changes. Investors will then calculate the volatility of Aeglea Bio's stock to predict their future moves. A delisted stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile delisted stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Aeglea Bio's volatility:
Historical Volatility
This type of delisted stock volatility measures Aeglea Bio's fluctuations based on previous trends. It's commonly used to predict Aeglea Bio's future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Aeglea Bio's current market price. This means that the delisted stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Aeglea Bio's to be redeemed at a future date.Transformation |
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
Aeglea Bio Projected Return Density Against Market
Given the investment horizon of 90 days the stock has the beta coefficient of 4.9195 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Aeglea Bio will likely underperform.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Aeglea Bio or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Aeglea Bio's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Aeglea delisted stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Aeglea Bio Therapeutics has an alpha of 4.237, implying that it can generate a 4.24 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Predicted Return Density |
Returns |
What Drives an Aeglea Bio Price Volatility?
Several factors can influence a delisted stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Aeglea Bio Stock Return Volatility
Aeglea Bio historical daily return volatility represents how much of Aeglea Bio delisted stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 0.0% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7357% volatility on return distribution over the 90 days horizon. Performance |
Timeline |
About Aeglea Bio Volatility
Volatility is a rate at which the price of Aeglea Bio or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Aeglea Bio may increase or decrease. In other words, similar to Aeglea's beta indicator, it measures the risk of Aeglea Bio and helps estimate the fluctuations that may happen in a short period of time. So if prices of Aeglea Bio fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. Aeglea BioTherapeutics, Inc. was founded in 2013 and is headquartered in Austin, Texas. Aeglea Biothera operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 69 people.
Aeglea Bio's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Aeglea Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Aeglea Bio's price varies over time.
3 ways to utilize Aeglea Bio's volatility to invest better
Higher Aeglea Bio's stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Aeglea Bio Therapeutics stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Aeglea Bio Therapeutics stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Aeglea Bio Therapeutics investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Aeglea Bio's stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Aeglea Bio's stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Aeglea Bio Investment Opportunity
Dow Jones Industrial has a standard deviation of returns of 0.74 and is 9.223372036854776E16 times more volatile than Aeglea Bio Therapeutics. Compared to the overall equity markets, volatility of historical daily returns of Aeglea Bio Therapeutics is lower than 0 percent of all global equities and portfolios over the last 90 days. You can use Aeglea Bio Therapeutics to enhance the returns of your portfolios. The stock experiences a large bullish trend. Check odds of Aeglea Bio to be traded at $0.649 in 90 days.Significant diversification
The correlation between Aeglea Bio Therapeutics and DJI is 0.09 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Aeglea Bio Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Aeglea Bio Additional Risk Indicators
The analysis of Aeglea Bio's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Aeglea Bio's investment and either accepting that risk or mitigating it. Along with some common measures of Aeglea Bio stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Risk Adjusted Performance | 0.0975 | |||
Market Risk Adjusted Performance | 0.9857 | |||
Mean Deviation | 11.03 | |||
Semi Deviation | 4.13 | |||
Downside Deviation | 8.67 | |||
Coefficient Of Variation | 823.83 | |||
Standard Deviation | 39.63 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar delisted stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Aeglea Bio Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
Visa vs. Aeglea Bio | ||
Microsoft vs. Aeglea Bio | ||
Nasdaq vs. Aeglea Bio | ||
GM vs. Aeglea Bio | ||
Armada Hflr vs. Aeglea Bio | ||
FrontView REIT, vs. Aeglea Bio | ||
Morgan Stanley vs. Aeglea Bio | ||
Citigroup vs. Aeglea Bio | ||
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Aeglea Bio as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Aeglea Bio's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Aeglea Bio's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Aeglea Bio Therapeutics.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in Aeglea Stock
If you are still planning to invest in Aeglea Bio Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aeglea Bio's history and understand the potential risks before investing.
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |